Watchlist Price Alert

Paratek Pharmaceuticals I... (PRTK)

NASDAQ: PRTK · Real-Time Price · USD

2.23

0.04 (1.83%)

At close: Sep 20, 2023, 8:00 PM

Paratek Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-63.57M	-59.08M	-96.54M	-128.79M	-112.36M	-89.07M	-111.64M
Depreciation & Amortization	490K	391K	578K	-1.29M	-1.07M	1.27M	2.3M
Stock-Based Compensation	12.32M	14.34M	10.25M	14.29M	25.49M	16.9M	10.79M
Other Working Capital	21.05M	22.33M	-2.64M	1.21M	839K	-3.41M	-413K
Other Non-Cash Items	5.41M	4.27M	1.52M	3.24M	2.72M	565K	-104K
Deferred Income Tax	n/a	n/a	1.06M	n/a	107K	743K	n/a
Change in Working Capital	-20.79M	-8.19M	-20.29M	-21.5M	3.92M	-8.24M	4.55M
Operating Cash Flow	-66.14M	-48.27M	-103.42M	-134.04M	-81.18M	-78.57M	-94.1M
Capital Expenditures	-36K	-373K	-376K	-239K	-60K	-1.12M	-690K
Cash Acquisitions	n/a	n/a	n/a	-239K	-715K	n/a	n/a
Purchase of Investments	-15.16M	-15.12M	-29.63M	-102.21M	-292.86M	-180.29M	-135.8M
Sales Maturities Of Investments	30M	20M	122.5M	237M	165.05M	138.75M	60.11M
Other Investing Acitivies	n/a	n/a	n/a	239K	715K	655K	1.63M
Investing Cash Flow	14.8M	4.51M	92.5M	134.55M	-127.87M	-42M	-74.76M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	5.09M	18.33M	11.34M	57.62M	220.73M	103.03M	90.52M
Financial Cash Flow	5.09M	18.33M	11.34M	57.62M	220.73M	103.03M	90.52M
Net Cash Flow	-46.24M	-25.43M	415K	58.13M	11.67M	-17.55M	-78.34M
Free Cash Flow	-66.18M	-48.65M	-103.8M	-134.28M	-81.24M	-79.69M	-94.79M